Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diazoxide in the management of patients with insulinoma.

Literature DB >> 3019020

Diazoxide in the management of patients with insulinoma.

P N Goode, J R Farndon, J Anderson, I D Johnston, J A Morte.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：
Diazoxide

Year: 1986 PMID： 3019020 DOI： 10.1007/bf01655532

Source DB: PubMed Journal: World J Surg ISSN： 0364-2313 Impact factor: 3.352

× No keyword cloud information.

15 in total

Review 1. CLINICAL AND PHYSIOLOGICAL IMPLICATIONS OF DIABETES INDUCED BY BENZOTHIADIAZINES.

Authors: F W WOLFF
Journal: Diabetes Date: 1964 Mar-Apr Impact factor: 9.461

2. Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.

Authors: A L Graber; D Porte; R H Williams
Journal: Ann N Y Acad Sci Date: 1968-04-11 Impact factor: 5.691

3. Hyperinsulinism. Surgical results and management of occult functioning islet cell tumor: review of 154 cases.

Authors: G P Laroche; D O Erris; J T Priestley; D A Scholz; M B Dockerty
Journal: Arch Surg Date: 1968-05

4. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.

Authors: A Loubatières; M M Mariani; R Alric
Journal: Ann N Y Acad Sci Date: 1968-04-11 Impact factor: 5.691

5. Diazoxide therapy of intractable hypoglycemia.

Authors: V Marks; E Samols
Journal: Ann N Y Acad Sci Date: 1968-04-11 Impact factor: 5.691

6. The surgical aspects of insulinomas.

Authors: J A van Heerden; A J Edis; F J Service
Journal: Ann Surg Date: 1979-06 Impact factor: 12.969

7. Is preoperative localisation of insulinomas necessary?

Authors: P R Daggett; E A Goodburn; A B Kurtz; L P Le Quesne; D V Morris; J D Nabarro; M J Raphael
Journal: Lancet Date: 1981-02-28 Impact factor: 79.321

8. Insulinoma: diagnosis, surgical management and long-term follow-up. Review of 41 cases.

Authors: D L Galbut; A M Markowitz
Journal: Am J Surg Date: 1980-05 Impact factor: 2.565

9. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas.

Authors: R C Turner; N W Oakley; J D Nabarro
Journal: Br Med J Date: 1971-04-17

10. Metastatic insulinoma with long survival and glucagonoma syndrome.

Authors: C M D'Arcangues; S Awoke; G D Lawrence
Journal: Ann Intern Med Date: 1984-02 Impact factor: 25.391

20 in total

1. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors: Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal: Pancreas Date: 2010-08 Impact factor: 3.327

Review 2. Drug-induced endocrine and metabolic disorders.

Authors: Ronald C W Ma; Alice P S Kong; Norman Chan; Peter C Y Tong; Juliana C N Chan
Journal: Drug Saf Date: 2007 Impact factor: 5.606

3. Glucagon regulates orexin A secretion in humans and rodents.

Authors: Ayman M Arafat; Przemysław Kaczmarek; Marek Skrzypski; Ewa Pruszyńska-Oszmałek; Paweł Kołodziejski; Aikaterini Adamidou; Stephan Ruhla; Dawid Szczepankiewicz; Maciej Sassek; Maria Billert; Bertram Wiedenmann; Andreas F H Pfeiffer; Krzysztof W Nowak; Mathias Z Strowski
Journal: Diabetologia Date: 2014-07-27 Impact factor: 10.122

Diazoxide in the management of patients with insulinoma.

Review 1. CLINICAL AND PHYSIOLOGICAL IMPLICATIONS OF DIABETES INDUCED BY BENZOTHIADIAZINES.

2. Clinical use of diazoxide and studies of the mechanism of its hyperglycemic effects in man.

3. Hyperinsulinism. Surgical results and management of occult functioning islet cell tumor: review of 154 cases.

4. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.

5. Diazoxide therapy of intractable hypoglycemia.

6. The surgical aspects of insulinomas.

7. Is preoperative localisation of insulinomas necessary?

8. Insulinoma: diagnosis, surgical management and long-term follow-up. Review of 41 cases.

9. Control of basal insulin secretion, with special reference to the diagnosis of insulinomas.

10. Metastatic insulinoma with long survival and glucagonoma syndrome.

1. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Review 2. Drug-induced endocrine and metabolic disorders.

3. Glucagon regulates orexin A secretion in humans and rodents.

Review 4. Insulinoma: pathophysiology, localization and management.

5. The surgical management of insulinomas in children.

6. Sporadic Insulinoma Presenting as Early Morning Night Terrors.

Review 7. Advances in the treatment of neuroendocrine tumors.

Review 8. Practical management and treatment of pancreatic neuroendocrine tumors.

Review 9. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances.

Review 10. Management of non-islet-cell tumor hypoglycemia: a clinical review.